AGNC vs HST

AGNC exhibits severe financial health concerns, as evidenced by a Piotroski F-Score of 3/9 (indicating weak fundamentals) and a missing Altman Z-Score, which raises unquantified distress risk. Despite a high intrinsic value estimate of $43.37 and a Graham Number of $17.64, the stock trades at $10.23, suggesting a potential undervaluation—however, this is undermined by extreme leverage (Debt/Equity: 6.89), near-zero liquidity (Current Ratio: 0.18), and a 97.96% payout ratio. The recent insider selling of $11.43M over six months signals strong bearish sentiment, while earnings have consistently missed expectations in the last four quarters. The 52-week range of $7.85–$12.19 reflects high volatility and lack of sustained momentum.

HST presents a stark dichotomy between strong fundamental growth and poor market sentiment. The company maintains a stable financial profile with a Piotroski F-Score of 4/9 and a very healthy Debt/Equity ratio of 0.84, which is significantly lower than the sector average of 2.86. While the current price of $20.14 is well below the growth-based intrinsic value of $32.45, the investment case is tempered by an extremely bearish technical trend (10/100) and negative insider sentiment. Strong YoY earnings growth of 27.10% and a consistent track record of earnings beats provide a solid fundamental floor.